Integrated Investment Consultants’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.88M | Sell |
11,330
-1
| -0% | -$233 | 0.57% | 36 |
|
|
2026
Q1 | $2.77M | Sell |
11,331
-858
| -7% | -$200K | 0.59% | 37 |
|
|
2025
Q4 | $2.52M | Buy |
12,189
+3,868
| +46% | +$765K | 0.49% | 43 |
|
|
2025
Q3 | $1.54M | Buy |
8,321
+72
| +0.9% | +$12.3K | 0.26% | 61 |
|
|
2025
Q2 | $1.26M | Sell |
8,249
-2,772
| -25% | -$426K | 0.25% | 67 |
|
|
2025
Q1 | $1.83M | Sell |
11,021
-2,005
| -15% | -$314K | 0.36% | 48 |
|
|
2024
Q4 | $1.88M | Sell |
13,026
-52,286
| -80% | -$8.1M | 0.39% | 50 |
|
|
2024
Q3 | $1.02M | Buy |
65,312
+61,421
| +1,579% | +$9.79M | 0.22% | 66 |
|
|
2024
Q2 | $615K | Hold |
3,891
| – | – | 0.17% | 104 |
|
|
2024
Q1 | $615K | Buy |
3,891
+84
| +2% | +$13.4K | 0.17% | 104 |
|
|
2023
Q4 | $597K | Sell |
3,807
-475
| -11% | -$72.8K | 0.19% | 95 |
|
|
2023
Q3 | $667K | Sell |
4,282
-892
| -17% | -$147K | 0.24% | 70 |
|
|
2023
Q2 | $856K | Sell |
5,174
-120
| -2% | -$19.4K | 0.27% | 54 |
|
|
2023
Q1 | $821K | Sell |
5,294
-629
| -11% | -$102K | 0.26% | 56 |
|
|
2022
Q4 | $1.05M | Buy |
5,923
+492
| +9% | +$85K | 0.35% | 44 |
|
|
2022
Q3 | $887K | Buy |
5,431
+113
| +2% | +$19.1K | 0.35% | 42 |
|
|
2022
Q2 | $944K | Sell |
5,318
-600
| -10% | -$107K | 0.34% | 43 |
|
|
2022
Q1 | $1.05M | Sell |
5,918
-1,555
| -21% | -$265K | 0.28% | 51 |
|
|
2021
Q4 | $1.28M | Sell |
7,473
-1,055
| -12% | -$173K | 0.34% | 47 |
|
|
2021
Q3 | $1.38M | Buy |
8,528
+159
| +2% | +$27.1K | 0.4% | 38 |
|
|
2021
Q2 | $1.38M | Buy |
8,369
+1,814
| +28% | +$300K | 0.4% | 38 |
|
|
2021
Q1 | $1.08M | Sell |
6,555
-998
| -13% | -$161K | 0.37% | 41 |
|
|
2020
Q4 | $1.19M | Buy |
7,553
+509
| +7% | +$75.1K | 0.45% | 41 |
|
|
2020
Q3 | $1.05M | Buy |
7,044
+125
| +2% | +$18.5K | 0.49% | 37 |
|
|
2020
Q2 | $973K | Sell |
6,919
-658
| -9% | -$95.9K | 0.46% | 39 |
|
|
2020
Q1 | $994K | Sell |
7,577
-918
| -11% | -$130K | 0.59% | 35 |
|
|
2019
Q4 | $1.24M | Sell |
8,495
-542
| -6% | -$73.5K | 0.51% | 39 |
|
|
2019
Q3 | $1.17M | Sell |
9,037
-810
| -8% | -$107K | 0.6% | 33 |
|
|
2019
Q2 | $1.37M | Sell |
9,847
-16
| -0.2% | -$2.21K | 0.7% | 29 |
|
|
2019
Q1 | $1.38M | Sell |
9,863
-2,274
| -19% | -$305K | 0.74% | 26 |
|
|
2018
Q4 | $1.57M | Sell |
12,137
-264
| -2% | -$36.8K | 0.84% | 21 |
|
|
2018
Q3 | $1.71M | Buy |
12,401
+39
| +0.3% | +$5.18K | 0.83% | 17 |
|
|
2018
Q2 | $1.5M | Sell |
12,362
-558
| -4% | -$69.6K | 0.79% | 18 |
|
|
2018
Q1 | $1.66M | Buy |
+12,920
| New | +$1.75M | 0.65% | 20 |
|
|
2017
Q3 | $1.57M | Sell |
12,103
-218
| -2% | -$28.9K | 0.68% | 19 |
|
|
2017
Q2 | $1.63M | Sell |
12,321
-202
| -2% | -$25.8K | 0.73% | 17 |
|
|
2017
Q1 | $1.56M | Sell |
12,523
-100
| -0.8% | -$11.9K | 0.71% | 18 |
|
|
2016
Q4 | $1.45M | Buy |
12,623
+1,125
| +10% | +$130K | 0.7% | 19 |
|
|
2016
Q3 | $1.36M | Sell |
11,498
-250
| -2% | -$30.3K | 0.69% | 20 |
|
|
2016
Q2 | $1.43M | Buy |
11,748
+1,153
| +11% | +$131K | 0.81% | 20 |
|
|
2016
Q1 | $1.15M | Buy |
10,595
+300
| +3% | +$31.1K | 0.66% | 21 |
|
|
2015
Q4 | $996K | Buy |
+10,295
| New | +$1.04M | 0.78% | 21 |
|
Other funds holding JNJ
Integrated Investment Consultants's JNJ Position: Q2 2026 in Review
Integrated Investment Consultants reduced its Johnson & Johnson (JNJ) stake by 0.01% in Q2 2026, selling an estimated $233 and leaving 11,330 shares worth $2.88M. The position accounts for 0.57% of the portfolio, ranked #36.
Integrated Investment Consultants first reported a position in JNJ in Q4 2015 and has held it in 42 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Integrated Investment Consultants held 11,330 shares of Johnson & Johnson worth $2.88M as of Q2 2026.
- Integrated Investment Consultants sold 1 Johnson & Johnson share in Q2 2026, an estimated $233.
- Johnson & Johnson made up 0.57% of Integrated Investment Consultants's portfolio in Q2 2026, its #36 holding.
- Integrated Investment Consultants first reported a position in Johnson & Johnson in Q4 2015 and has held it in 42 quarters since.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Integrated Investment Consultants's 13F filing for Q2 2026, filed 17 Aug 2026.